Eastern European Pharma News In Brief
Hungarian retail drug sales in August 1997 were 14% up on those ofAugust 1996, say Central Statistical Office data reported by MTI Econews. Also, retail drug sales in September were 22% higher than in September 1996.
- The retail price of health care in the Slovak Republic in October was 14.3% higher than in October 1996, say Slovak Statistical Office data reported by CTK Business News. In comparison, Slovakia's inflation rate in October was only 5.9% higher than the year before.
- Despite a degree of privatization in Bulgaria's drug industry, most domestic drugmakers are owned either by the state or by the Pharmachim Holding Company, reports the Bulgarian Economic Review. The Bulgarian Privatization Agency is currently formulating proposals for the sale of state-owned drugmakers, which could see strategic investors gaining control of up to 55% of shares in these firms.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze